American Vanguard (AVD) Projected to Announce Quarterly Earnings on Thursday

American Vanguard (NYSE:AVD) is expected to post its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect the company to post earnings of $0.09 per share and revenue of $135.00 million for the quarter. Individuals can check the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 6, 2026 at 5:00 PM ET.

American Vanguard (NYSE:AVD) last issued its quarterly earnings data on Wednesday, May 6th. The basic materials company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.08). The company had revenue of $123.57 million during the quarter, compared to the consensus estimate of $120.00 million. American Vanguard had a negative net margin of 8.71% and a negative return on equity of 4.13%.

American Vanguard Stock Performance

NYSE AVD opened at $2.63 on Tuesday. The firm’s fifty day moving average price is $2.71 and its two-hundred day moving average price is $3.38. The stock has a market cap of $75.39 million, a PE ratio of -1.66 and a beta of 1.41. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.41 and a current ratio of 2.32. American Vanguard has a fifty-two week low of $2.05 and a fifty-two week high of $5.92.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered American Vanguard from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, May 18th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.

Insiders Place Their Bets

In other news, Director Patrick E. Gottschalk acquired 25,000 shares of American Vanguard stock in a transaction on Tuesday, May 19th. The stock was acquired at an average cost of $2.70 per share, with a total value of $67,500.00. Following the transaction, the director owned 191,705 shares of the company’s stock, valued at approximately $517,603.50. This trade represents a 15.00% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 5.60% of the company’s stock.

Hedge Funds Weigh In On American Vanguard

Hedge funds have recently modified their holdings of the company. Wellington Management Group LLP grew its holdings in shares of American Vanguard by 4.4% in the fourth quarter. Wellington Management Group LLP now owns 1,700,161 shares of the basic materials company’s stock valued at $6,495,000 after acquiring an additional 71,632 shares in the last quarter. Geode Capital Management LLC lifted its holdings in American Vanguard by 2.2% during the second quarter. Geode Capital Management LLC now owns 639,301 shares of the basic materials company’s stock worth $2,506,000 after acquiring an additional 13,657 shares during the period. AQR Capital Management LLC lifted its holdings in American Vanguard by 117.8% during the first quarter. AQR Capital Management LLC now owns 436,687 shares of the basic materials company’s stock worth $1,921,000 after acquiring an additional 236,212 shares during the period. JPMorgan Chase & Co. boosted its position in American Vanguard by 12.9% in the third quarter. JPMorgan Chase & Co. now owns 436,398 shares of the basic materials company’s stock worth $2,505,000 after purchasing an additional 50,004 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its position in American Vanguard by 1,397.5% in the fourth quarter. Russell Investments Group Ltd. now owns 336,277 shares of the basic materials company’s stock worth $1,285,000 after purchasing an additional 313,821 shares during the last quarter. Institutional investors own 79.00% of the company’s stock.

About American Vanguard

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.